Abstract Topics

Care of the Carer (Healthcare Team and Caregiver)

This category accepts abstracts on pharmacological research in the context of HSCT, such as pharmacodynamic and pharmacokinetic studies, novel approaches to conditioning, adverse effect identification and prevention and infectious and non-infectious complication prevention. Abstracts on organisational issues of on-site pharmacies are also welcome.

Complementary Therapies

This category accepts abstracts on the delivery of complementary therapies (relaxation training, meditation, mindfulness, massage therapy, music therapy, etc.) by nursing staff in the setting of HSCT and cellular therapy.

Donor Care

This category accepts abstracts on topics related to donor care, donor rights and physical and mental wellbeing before and after donation of stem cells (both adults and minors). Abstracts can also be for qualitative and quantitative research done with donors and healthcare professionals to capture their experience and individual aspects of the donation process. Abstracts on donor care needs of potential donors and other family members who are not HLA-identical or eligible are also welcome.

Ethical Issues

This category accepts abstracts on the ethical issues faced by nurses in the setting of HSCT and cellular therapies, e.g. informed consent, ethical dilemmas in HSCT patient care and the allocation of resources.

Impact of New Therapies on Patient Care

This category accepts abstracts on new therapies, including cellular and gene therapies or novel indications, and their impact on patient care, qualitative and quantitative research on innovative therapeutics in terms of drugs, techniques, nursing care; patient experience.

Education and Training

This category accepts abstracts on education and training programmes, identification of gaps in professional preparation and skills needed, and on how to maintain skills and competencies in the field of HSCT and cellular therapies.

Management

This category accepts abstracts on nurse management, leadership and professional issues in the field of HSCT and cellular therapies.

Outpatient Developments and Ambulatory Care

This category accepts abstracts on all aspects of the outpatient model of care, in which specialised HSCT and/or cellular therapy care is delivered to patients in their homes, or in the outpatient setting for illnesses/procedures that would normally require hospitalisation.

Advanced Care Planning, Palliative and End of Life Care

This category accepts abstracts on needs assessment, developing and implementing advanced care planning (fostering early discussion and consideration of patient’s end-of-life treatment preferences), palliative approaches and end-of-life care.

Patient Safety and Standards of Care

This category accepts abstracts on researching, improving and implementing procedures to enhance patient safety prior to, during and after HSCT or cellular therapy and to develop and maintain high standards of care.

Psycho-social Issues

This category accepts abstracts on the short- and long-term psycho-social morbidity and health-related quality of life of patients who underwent HSCT or cellular therapies, their relatives and carers from the nursing perspectives. Abstracts on the role of nurses in the multidisciplinary teams involved in HSCT are also welcome.

Vaccination, Infection Control and Prevention

This category accepts abstracts on nursing aspects and involvement in vaccination programmes, infection control measures to prevent hospital- and community-acquired infections, developing standard operating procedures to minimise the risks of infections.

Quality of Life, Late Effects, Survivorship Care and Health Promotion

This category accepts abstracts on initiatives to optimise long-term outcomes and quality of life, mitigate late effects and deliver holistic care to survivors of HSCT, cell and gene therapy and to promote health in this category of patients.

Symptom Management and Supportive Care

This category accepts abstracts on early recognition and monitoring of signs and symptoms of possible complications encountered by patients who undergo HSCT and cell therapies, including GvHD. Abstracts on the delivery of palliative andsupportive care (behavioural and pharmacological interventions to reduce treatment-related fatigue and improve quality of life) are also welcome.

 Cell and Gene therapy (CART, IEC)

This category accepts abstracts on nursing implications and specific care needed when caring for individuals who underwent cellular therapy using CAR-T or immune cells.

Quality Management and JACIE

This category accepts abstracts on securing quality of nursing, obtaining JACIE accreditation and maintaining regulatory requirements in HSCT centres. Abstracts on the impact of JACIE on the quality of care delivered by nurses in the setting of HSCT and on the general implications of JACIE for nurses are also welcome.

Transplant and CAR-T Coordination, and Early Follow-up

This category accepts abstracts on pre- and post-transplant/cellular therapy care coordination, and programmes aimed at providing practice frameworks to enable monitoring of patients after transplant or cellular therapies.

Advanced Nursing Practise

This category accepts abstracts on the development of advanced nursing practice in the setting of HSCT and cellular therapy considering these roles or skills, e.g. bone marrow sampling, HLA typing, transplant recipient care. Abstracts on improving workflow efficiency and patient care delivery through leadership, evidence-based practice and nursing practice are welcome

 Nursing Research in Transplant, Cell and Gene Therapy

This category accepts abstracts that provide evidence on which to base new standards of care, helping to enhance safety and efficacy of nursing practice in a vulnerable patient population. Abstracts on systematic analysis of procedures to examine how resources are used and the effect care has on patients’ outcomes and quality of life are also welcome.

 Artificial Intelligence and Digital Solutions in HSCT Nursing

This category accepts abstracts on the use of digital solutions and artificial intelligence to modernise and standardise aspects of patient and donor care. Abstracts on ethical and legal considerations of digital solutions are also welcome.

Patient and Donor Information and Education

This category accepts abstracts on the development of novel approaches to provide therapy-specific knowledge delivered by nurses to patients and donors on what to expect before, during and after transplant or cell therapy.

Paediatric and AYA/TYA Care

This category accepts abstracts on all age-appropriate aspects of care for paediatric patients and adolescent/teenage and young adults, and service adaptations to meet the changing needs of patients and their families to help the transition into adulthood in the context of long-term follow-up post-HSCT.

Outreach Programmes for HCT, Cell and Gene Therapy in Low Resource Settings

This category accepts abstracts on designing and organising educational HSCT nursing events in low- and middle-income countries with limited access to HSCT and cellular therapies. Abstracts on collaborations with non-profit organisations and outreach missions are also welcome.